Nadixa (Nadifloxacin)

Nadifloxacin, the active ingredient in Nadixa, is a fluoroquinolone antibiotic presented as a topical formulation for skin use. It is applied to the affected area to treat bacterial skin infections and is indicated for conditions such as acne vulgaris and impetigo in adult and adolescent patients. GNH USA supplies Nadixa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nadifloxacin is a topical fluoroquinolone used to treat bacterial skin conditions. - Acne vulgaris: reduces inflammatory lesions caused by Propionibacterium acnes. - Impetigo: eradicates Streptococcus and Staphylococcus species responsible for superficial skin infection. - Folliculitis: clears infected hair follicles and promotes healing. - Infected eczema: controls bacterial overgrowth and alleviates associated inflammation.

Topical nadifloxacin may cause local and systemic adverse reactions.

Common Side Effects: - Burning sensation at the application site. - Pruritus or itching. - Redness or erythema. - Dryness or peeling of the skin. - Mild headache. - Transient skin irritation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Tendon rupture or tendonitis. - Photosensitivity leading to severe sunburn. - Persistent ulceration or delayed wound healing. - Systemic fluoroquinolone toxicity (rare with topical use).

Before using Nadixa, consider the following safety measures. - Contraindication: Do not apply to patients with known hypersensitivity to fluoroquinolones. - Caution: Avoid use on large body surface areas or broken skin to limit systemic absorption. - Interaction: Do not combine with other topical antibiotics unless directed by a clinician. - Pregnancy & lactation: Use only if the benefit outweighs potential risk; consult a healthcare professional. - Storage: Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nadixa may interact with other medications; monitor the following.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity. - Corticosteroids (systemic or high‑potency topical): may enhance risk of skin thinning and delayed healing.

Moderate Interactions (Monitor Closely): - Antacids or supplements containing aluminum, magnesium, calcium, or iron: may reduce absorption if systemic exposure occurs. - Warfarin: topical use rarely affects coagulation, but monitor INR if systemic fluoroquinolone is also used. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of photosensitivity reactions.